LAUNXP Biomedical Co., Ltd carries a market capitalization of 800.33M, placing it among publicly traded companies globally.
| Market Cap | 800.33M |
| Enterprise Value | N/A |
LAUNXP Biomedical Co., Ltd's stock has declined approximately -28.90792% over the past 52 weeks. The 50-day moving average sits at 18.25, while the 200-day moving average is 21.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | -28.90792% |
| 50-Day Moving Average | 18.25 |
| 200-Day Moving Average | 21.81 |
| Average Volume (20 Days) | N/A |